1) To gain a broad overview of the disease symptom picture of AD and its associated neuropathology and imaging features. 2) To review the cognitive and biomarker profiles in AD and discuss ways that new research may inform the clinical diagnosis. 3) To gain an overview of the research being done in the presymptomatic phase of AD including emerging neuroimaging and biomarkers changes that occur prior to overt symptom onset.
Alzheimer’s Disease (AD) is the disease of our time. It affects over 35 million worldwide, and the numbers will rise as society ages. The health care costs of AD are staggering. While other common causes of death in the elderly are declining, AD is increasing. This symposium will provide an overview of the disease from multiple angles and discuss insights gained from the latest advances in research on its neurobiology and early diagnosis.
Johnson, S,
Neurobiology and Imaging Research in Alzheimer's Disease. Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL.
http://archive.rsna.org/2014/13011786.html
